CoChat

Deficiency in type I interferon signaling prevents the early interferon-induced gene signature in pancreatic islets but not type 1 diabetes in NOD mice

Quah, Hong Sheng, Miranda-Hernandez, Socorro, Khoo, Aimee, Harding, Ashley, Fynch, Stacey, Elkerbout, Lorraine, Brodnicki, Thomas C., Baxter, Alan G., Kay, Thomas W.H., Thomas, Helen E., Graham, Kate L. · 2014 · Diabetes
Cited by 32

The DOI matches its Crossref record.

Abstract

Type I interferons (IFNs) have been implicated in the initiation of islet autoimmunity and development of type 1 diabetes. To directly test their involvement, we generated NOD mice deficient in type I IFN receptors (NOD.IFNAR1−/−). Expression of the type I IFN-induced genes Mx1, Isg15, Ifit1, Oas1a, and Cxcr4 was detectable in NOD islets as early as 1 week of age. Of these five genes, expression of Isg15, Ifit1, Oas1a, and Mx1 peaked at 3–4 weeks of age, corresponding with an increase in Ifnα mRNA, declined at 5–6 weeks of age, and increased again at 10–14 weeks of age. Increased IFN-induced gene expression was ablated in NOD.IFNAR1−/− islets. Loss of Toll-like receptor 2 (TLR2) resulted in reduced islet expression of Mx1 at 2 weeks of age, but TLR2 or TLR9 deficiency did not change the expression of other IFN-induced genes in islets compared with wild-type NOD islets. We observed increased β-cell major histocompatibility complex class I expression with age in NOD and NOD.IFNAR1−/− mice. NOD.IFNAR1−/− mice developed insulitis and diabetes at a similar rate to NOD controls. These results indicate type I IFN is produced within islets in young mice but is not essential for the initiation and progression of diabetes in NOD mice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db13-1210

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 25

  1. Calderon, 2008, Dendritic cells in islets of Langerhans constitutively present beta cell-derived peptides bound to their class II MHC molecules, Proc Natl Acad Sci U S A, 105, 6121, 10.1073/pnas.0801973105 · DOI · Paper page
  2. Dahlén, 1998, Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse, J Immunol, 160, 3585, 10.4049/jimmunol.160.7.3585 · DOI · Paper page
  3. Jansen, 1994, Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice, Diabetes, 43, 667, 10.2337/diab.43.5.667 · DOI · Paper page
  4. Rosmalen, 2000, Islet abnormalities associated with an early influx of dendritic cells and macrophages in NOD and NODscid mice, Lab Invest, 80, 769, 10.1038/labinvest.3780080 · doi:10.1038/labinvest.3780080
  5. Van Belle, 2012, Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets, Immunity, 36, 1060, 10.1016/j.immuni.2012.04.005 · DOI
  6. Huang, 1995, Interferon expression in the pancreases of patients with type I diabetes, Diabetes, 44, 658, 10.2337/diab.44.6.658 · DOI · Paper page
  7. Bottazzo, 1985, In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis, N Engl J Med, 313, 353, 10.1056/NEJM198508083130604 · DOI · Paper page
  8. Foulis, 1987, Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus, Lancet, 2, 1423, 10.1016/S0140-6736(87)91128-7 · DOI · Paper page
  9. Stewart, 1993, Induction of type I diabetes by interferon-alpha in transgenic mice, Science, 260, 1942, 10.1126/science.8100367 · DOI · Paper page
  10. Carrero, 2013, Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse, PLoS ONE, 8, e59701, 10.1371/journal.pone.0059701 · DOI · Paper page
  11. Diana, 2013, Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes, Nat Med, 19, 65, 10.1038/nm.3042 · DOI · Paper page
  12. Li, 2008, Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice, Proc Natl Acad Sci U S A, 105, 12439, 10.1073/pnas.0806439105 · DOI · Paper page
  13. Müller, 1994, Functional role of type I and type II interferons in antiviral defense, Science, 264, 1918, 10.1126/science.8009221 · DOI · Paper page
  14. Chong, 2004, Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction, J Immunol, 172, 5714, 10.4049/jimmunol.172.9.5714 · DOI · Paper page
  15. Mollah, 2012, Granzyme B is dispensable in the development of diabetes in non-obese diabetic mice, PLoS ONE, 7, e40357, 10.1371/journal.pone.0040357 · DOI
  16. Thomas, 1998, IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes, J Clin Invest, 102, 1249, 10.1172/JCI2899 · DOI · Paper page
  17. Graham, 2011, Autoreactive cytotoxic T lymphocytes acquire higher expression of cytotoxic effector markers in the islets of NOD mice after priming in pancreatic lymph nodes, Am J Pathol, 178, 2716, 10.1016/j.ajpath.2011.02.015 · DOI
  18. Driver, 2011, Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease, Semin Immunopathol, 33, 67, 10.1007/s00281-010-0204-1 · DOI · Paper page
  19. O’Brien, 2006, A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse, J Autoimmun, 26, 104, 10.1016/j.jaut.2005.11.006 · DOI
  20. Kim, 2007, Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes, Immunity, 27, 321, 10.1016/j.immuni.2007.06.010 · DOI · Paper page
  21. Zhang, 2010, TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes, J Immunol, 184, 5645, 10.4049/jimmunol.0901814 · DOI
  22. Wong, 2008, The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice, Ann N Y Acad Sci, 1150, 146, 10.1196/annals.1447.039 · DOI
  23. Leiter, 2002, Mice with targeted gene disruptions or gene insertions for diabetes research: problems, pitfalls, and potential solutions, Diabetologia, 45, 296, 10.1007/s00125-001-0743-z · DOI
  24. Allen, 2009, Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture, Diabetes, 58, 138, 10.2337/db08-0964 · DOI
  25. Li, 2011, The role of interferon alpha in initiation of type I diabetes in the NOD mouse, Clin Immunol, 140, 3, 10.1016/j.clim.2011.04.010 · DOI

Cited by

Metadata

Authors
Quah, H. S., Miranda-Hernandez, S., Khoo, A., Harding, A., Fynch, S., Elkerbout, L., Brodnicki, T. C., Baxter, A. G., Kay, T. W. H., Thomas, H. E., & Graham, K. L.
Affiliations
  • St. Vincent’s Institute, Fitzroy, Australia
  • Comparative Genomics Centre, James Cook University, Townsville, Australia
Venue
Diabetes
Published
2014-02-13
Volume
63
Issue
3
Pages
1032-1040
ISSN
  • 0012-1797
  • 1939-327X
Cited by
32
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.